Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Echo Health Ventures
AddedFeb 13, 2024
UpdatedJun 28, 2026
Echo Health Ventures

Echo Health Ventures

Operating

Echo Health Ventures: A US-based venture capital firm investing in innovative healthcare companies.

Location
Seattle, WA, US
Founded
2016
Firm
Compare
Portfolio
Employees
Website

Investments

Optura
Optura

Total Raised

$17.5M

Rounds

1

Series A$17.5MMay 2026
Main Street Health
Main Street Health

Total Raised

$342M

Rounds

2

Series Unknown$315MOctober 2023
Sempre Health
Sempre Health

Total Raised

$45.5M

Rounds

5

Series Unknown$20MSeptember 2023
Octave Bioscience
Octave Bioscience

Total Raised

$91M

Rounds

6

Series B$32.5MJuly 2023
Series B$32MDecember 2020
Strive Health
Strive Health

Total Raised

$386M

Rounds

3

Series C$166MMay 2023
Series B$140MMarch 2021
Cortica
Cortica
Series D

Total Raised

$175M

Rounds

7

Series D$75MApril 2023
Medix Infusion
Medix Infusion
Debt

Total Raised

$35M

Rounds

2

Series B$35MJanuary 2023
DispatchHealth
DispatchHealth

Total Raised

$733.2M

Rounds

7

Series E$330MNovember 2022
Series D$200MMarch 2021
Upfront Healthcare Services
Upfront Healthcare Services

Total Raised

$30.5M

Rounds

4

Series C$10.5MSeptember 2022
Series B$11.5MNovember 2020
Abacus Insights
Abacus Insights

Total Raised

$81.6M

Rounds

4

Series C$28MJune 2022
Embold Health
Embold Health

Total Raised

$47.9M

Rounds

3

Series B$23MMarch 2022
Wildflower Health
Wildflower Health

Total Raised

$40.8M

Rounds

5

Series Unknown$26MMarch 2022
Scipher Medicine
Scipher Medicine

Total Raised

$227M

Rounds

6

Series D$110MFebruary 2022
Series C$82MMarch 2021
mPulse Mobile
mPulse Mobile

Total Raised

$42M

Rounds

6

Series UnknownJanuary 2022
Series C$16MAugust 2020
Genome Medical
Genome Medical

Total Raised

$120.4M

Rounds

6

Series C$60MAugust 2021
Series B$14MJuly 2020
Ideon
Ideon

Total Raised

$44.1M

Rounds

6

Series B$23MApril 2021
Cityblock Health
Cityblock Health

Total Raised

$891.3M

Rounds

9

Series C$192MMarch 2021
Series B$53.5MJuly 2020